Phimedix Plc

Phimedix (PHM)

Company name:Phimedix Plc
EPIC:PHMTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BLM14N85
Market Segment:ASQ1Share Type:DE
WWW Address: 0.1P
 Price Price Change [%] Bid Offer Open High Low Volume
 0.95 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 0.92 97.25 -0.01 -0.20 - - - -

Phimedix Key Figures

(at previous day's close)
Market Cap.0.92m
Shares In Issue97.25m
Prev. Close0.95
PE Ratio- 
Dividend Yield-%
EPS - basic-0.20p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-p
Return On Equity (ROE)-172.88%
Operating Margin-%
PEG Factor- 
EPS Growth Rate99.62%
Dividends PS Growth Rate-%
Net Debt-0.11m
Gross Gearing66.85%
Quick Assets0.36m
Net Working Capital0.12m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-0.21p
Retained Profit PS-0.21p
Cash PS0.36p
Net Cash PS0.11p
Net Tangible Asset Value PS *0.12p
Net Asset Value PS0.12p
Spread- (-%) 

Phimedix Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Phimedix Historic Returns

Sorry No Data Available

Phimedix Key Management Ratios

Phimedix Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.04 
Tobin's Q Ratio (excl. intangibles)0.04 
Dividend Yield-%
Market-to-Book Ratio7.83 
Price-to-Pre-Tax Profit PS-4.53 
Price-to-Retained Profit PS-4.53 
Price-to-Cash Flow PS- 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS7.83 
Price-to-Cash PS2.65 
Net Working Capital PS0.12 
Price Pct to Working Capital PS7.83%
Earnings Yield-%
Average PE0.17 
Years in average2 
PE to PE average-%

Phimedix Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-30.90%
Net Gearing (excl. Intangibles)-30.90%
Gross Gearing66.85%
Gross Gearing (excl. Intangibles)66.85%
Gearing Under 1 Year66.85%
Gearing Under 1 Year (excl. Intgbl)66.85%
(Liquidity Ratios)
Net Working Capital to Total Assets33.15%
Current Ratio1.50 
Quick Ratio (Acid Test)1.50 
Liquidity Ratio1.46 
Cash & Equiv/Current Assets97.75%
(Solvency Ratios)
Enterprise Value0.58m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.26 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-1.17 
Total Debt0.24m
Total Debt/Net Current Assets2.02%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)

Phimedix Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-172.88%
Return On Assets (ROA)-0.83%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-172.88%
Return On Investment (ROI)-28.41%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debt Collection Period-Days

Phimedix Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
21 Jan 2015InterimGBX0.1930/03/201430/09/201421/01/201522/01/201529/01/20150.19

Phimedix Fundamentals

 31 Mar 2017 (HKD)31 Mar 2018 (HKD)31 Mar 2019 (HKD)31 Mar 2020 (GBP)
pre tax profit1.110.14%1.800.21%-64.77-17.83%-0.20-m
attributable profit1.030.13%1.690.20%-65.66-18.08%-0.20-m
retained profit1.030.13%1.690.20%-65.66-18.08%-0.20-m
eps - basic (p)8.00 1.40 -53.10 -0.20 
eps - diluted (p)8.00 1.30 -53.10 -0.20 
dividends per share- - - - 

Phimedix Balance Sheet

 31 Mar 2017 (HKD)31 Mar 2018 (HKD)31 Mar 2019 (HKD)31 Mar 2020 (GBP)
 31 Mar 2017 (HKD)31 Mar 2018 (HKD)31 Mar 2019 (HKD)31 Mar 2020 (GBP)
fixed assets fixed assets40.4847.16%40.5739.02%17.6636.02%--m
intangibles intangibles1.561.81%1.461.40%--%--m
fixed investments fixed investments--%--%--%--m
current assets - other current assets - other--%--%--%--m
stocks stocks35.1540.96%25.7924.81%3.066.23%--m
debtors debtors7.358.56%23.8722.96%19.3639.50%0.01-m
cash & securities cash & securities1.291.50%12.2811.81%8.9418.24%0.35-m
creditors - short creditors - short20.8524.30%36.9735.56%47.7097.31%0.24-m
creditors - long creditors - long0.160.18%0.140.13%0.120.24%--m
creditors - other creditors - other--%--%--%--m
subordinated loans subordinated loans--%--%--%--m
insurance funds insurance funds--%--%--%--m
ord cap, reserves ord cap, reserves64.8175.52%66.8664.31%1.202.45%0.12-m
prefs, minorities prefs, minorities--%--%--%--m
NAV Basic- - - - 
NAV Diluted- - - - 

Phimedix Cash Flow Statement

31 Mar 2017 (HKD)31 Mar 2018 (HKD)31 Mar 2019 (HKD)31 Mar 2020 (GBP)
Operating CF-5.3912.32-3.99-m
Pre-Financing CF-5.4112.32-4.000.10m
Retained CF-4.9412.32-4.000.35m

Phimedix Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210921 03:30:46